Suppr超能文献

不同类型的多巴胺D-2受体可能参与大鼠的打哈欠和刻板行为。

Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.

作者信息

Yamada K, Nagashima M, Kimura H, Matsumoto S, Furukawa T

机构信息

Department of Pharmacology, School of Medicine, Fukuoka University, Japan.

出版信息

Psychopharmacology (Berl). 1990;100(2):141-4. doi: 10.1007/BF02244396.

Abstract

The present experiments were performed to investigate differences in the properties of the dopamine D-2 receptors related to yawning and stereotypy. Subcutaneous injection of talipexole (B-HT 920) (10-250 micrograms/kg) or SND 919 ((S)-2-amino-4,5,6,7-tetrahydro-6-propylamino-benzothiazole) (25-500 micrograms/kg) evoked yawning behavior with bell-shaped responses. However, SK&F 38393 (1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol) (0.5-10 mg/kg SC) did not elicit yawning and decreased yawning responses to low doses of talipexole (25 micrograms/kg SC) or SND 919 (100 micrograms/kg SC). These low but effective doses for inducing yawning of talipexole or SND 919 in combination with SK&F 38393 (0.5-10 mg/kg SC) did not elicit stereotypy. In contrast, yawning behavior was not produced after very high doses of talipexole (500 micrograms/kg SC) or SND 919 (1000 micrograms/kg SC) given alone or in combination with SK&F 38393 (0.5-10 mg/kg SC). These extremely high doses of talipexole or SND 919 evoked slight stereotypy, which was enhanced by the combined treatment with SK&F 38393. The present results suggest that the dopamine D-2 receptors related to yawning are more sensitive to dopamine receptor agonists than those related to stereotypy, and that concurrent stimulation of postsynaptic dopamine D-1 receptors with D-2 receptors reduces the incidence of yawning but enhances that of stereotypy.

摘要

进行本实验是为了研究与打哈欠和刻板行为相关的多巴胺D-2受体特性的差异。皮下注射泰必利(B-HT 920)(10 - 250微克/千克)或SND 919((S)-2-氨基-4,5,6,7-四氢-6-丙基氨基-苯并噻唑)(25 - 500微克/千克)会诱发呈钟形反应的打哈欠行为。然而,SK&F 38393(1-苯基-2,3,4,5-四氢-(1H)-3-苯并氮杂卓-7,8-二醇)(0.5 - 10毫克/千克皮下注射)不会引发打哈欠,并且会降低对低剂量泰必利(25微克/千克皮下注射)或SND 919(100微克/千克皮下注射)的打哈欠反应。这些用于诱导泰必利或SND 919打哈欠的低但有效剂量与SK&F 38393(0.5 - 10毫克/千克皮下注射)联合使用时不会引发刻板行为。相反,单独或与SK&F 38393(0.5 - 10毫克/千克皮下注射)联合给予非常高剂量的泰必利(500微克/千克皮下注射)或SND 919(1000微克/千克皮下注射)后不会产生打哈欠行为。这些极高剂量的泰必利或SND 919会诱发轻微的刻板行为,与SK&F 38393联合治疗会增强这种行为。目前的结果表明,与打哈欠相关的多巴胺D-2受体比与刻板行为相关的受体对多巴胺受体激动剂更敏感,并且突触后多巴胺D-1受体与D-2受体的同时刺激会降低打哈欠的发生率,但会增加刻板行为的发生率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验